+905423212512 24/7 patient support
English
EUR
Neurosurgery

Autoimmune Encephalitis Treatment in Turkey

Autoimmune encephalitis is a serious neurological condition where the body's immune system mistakenly attacks healthy brain tissues. It affects individuals of any age, causing rapid cognitive decline, seizures, movement disorders, or behavioural changes that prompt urgent medical evaluation. Subsequent medical care and treatment options depend on a comprehensive specialist assessment and accurate diagnostic antibody testing. Compare hospitals in Turkey that treat Autoimmune Encephalitis and get a free review of your medical records.

3 min read

Autoimmune Encephalitis Treatment in Turkey
Price from
Price on request
Clinics
2

Verified surgeons for Autoimmune Encephalitis

1 doctor Compare doctors, ratings and prices — ask any of them for a free quote.

About Autoimmune Encephalitis

Autoimmune encephalitis is a serious neurological condition where the body's immune system mistakenly attacks healthy brain tissues. It affects individuals of any age, causing rapid cognitive decline, seizures, movement disorders, or behavioural changes that prompt urgent medical evaluation. Subsequent medical care and treatment options depend on a comprehensive specialist assessment and accurate diagnostic antibody testing.

Specialty: Neurosurgery

Best Clinics for Autoimmune Encephalitis Treatment in Turkey

Frequently asked questions

The cost of treating Autoimmune Encephalitis depends on the diagnosis and the treatment chosen. Doctors first review your medical records — free of charge — and you then receive an itemised quote.

Autoimmune Encephalitis is treated by Neurosurgery specialists. 2 clinics in Turkey on our platform offer this treatment.

What Is Autoimmune Encephalitis and Typical Symptoms

Autoimmune encephalitis is a serious inflammatory condition in which the body's immune system mistakenly attacks healthy brain tissue, surface receptors, or synaptic proteins. Unlike infectious encephalitis caused by microbes, this condition is driven by autoantibodies—such as anti-NMDAR, anti-LGI1, or anti-CASPR2—that impair neuronal signalling and cause cerebral inflammation.

Symptoms often progress over days or weeks, frequently beginning with non-specific malaise followed by acute neuro-psychiatric disturbances. Typical symptoms include:

  • Cognitive and memory deficits: Rapidly developing short-term memory loss, confusion, disorientation, and speech deterioration.
  • Psychiatric and behavioural changes: Agitation, psychosis, hallucinations, delusions, and catatonia, often prompting initial consultation in psychiatry & addiction services.
  • Seizures and movement disorders: New-onset focal or generalised seizures, status epilepticus, and abnormal movements such as faciobrachial dystonic seizures or oro-facial dyskinesias.
  • Autonomic and sleep disturbances: Fluctuating blood pressure, cardiac arrhythmias, hypoventilation requiring mechanical ventilation, severe insomnia, or altered consciousness ranging from lethargy to coma.

Because early signs overlap with primary psychiatric illnesses, prompt hospital admission and specialist evaluation are essential to prevent permanent neurological damage.

How Autoimmune Encephalitis Is Diagnosed

Accurate diagnosis requires confirming central nervous system inflammation and identifying causative autoantibodies. Hospitals in Turkey providing advanced neurological care utilise comprehensive diagnostic protocols coordinated through their check-ups & diagnostics departments.

Standard investigations include:

  • Lumbar puncture (CSF analysis): Cerebrospinal fluid is tested for lymphocytic pleocytosis, elevated protein, oligoclonal bands, and paired serum-CSF antibody panels.
  • High-resolution brain MRI: Contrast-enhanced 3T magnetic resonance imaging evaluates hyperintensities within the temporal lobes or limbic system. Normal scans can occur in early stages.
  • Continuous electroencephalogram (EEG): Identifies background slowing, subclinical seizures, or distinctive patterns such as extreme delta brush.
  • Tumour screening: Because certain forms are paraneoplastic, full screening is essential to detect underlying neoplasms, such as ovarian teratomas or testicular tumours. Hospitals perform pelvic or testicular ultrasound, CT, or PET-CT scans, coordinating with oncology specialists if a tumour is present.

Patients should bring previous discharge summaries, brain MRI scans on DICOM discs, CSF laboratory results, a list of current medications, and video clips of observed seizures or abnormal movements.

Treatment Options for Autoimmune Encephalitis

Treatment suppresses the aberrant immune response, clears pathogenic antibodies, and addresses underlying triggers. Clinical decisions are made by the treating doctor after reviewing tests, antibody titres, and disease severity.

Option Typically used when Things to know
First-Line Immunotherapy Initiated immediately upon suspected or confirmed diagnosis (corticosteroids, IVIG, or plasma exchange). High-dose intravenous corticosteroids reduce acute inflammation. Intravenous immunoglobulin (IVIG) and plasma exchange (plasmapheresis) clear circulating autoantibodies from the bloodstream.
Second-Line Immunotherapy Administered when first-line therapies show inadequate response after 10 to 14 days (e.g. rituximab or cyclophosphamide). Rituximab depletes antibody-producing B cells, while cyclophosphamide provides broader immunosuppression for severe refractory presentations. Blood counts must be monitored closely.
Surgical Tumour Resection Indicated when imaging identifies an associated tumour, such as an ovarian teratoma. Resecting the tumour removes the antigenic stimulus driving the autoimmune attack, often coordinated with neurosurgery or surgical specialists.
Supportive Care and Rehabilitation Maintained across all stages to manage complications and restore function. Incorporates anti-seizure drugs, intensive care support for autonomic instability, and multidisciplinary rehabilitation for cognitive and physical recovery.

Recovery is typically gradual. While many patients show marked improvement, rehabilitation may continue for several months to help regain memory, speech, and independence.

Planning Your Medical Journey to Turkey

Due to the complexity of autoimmune encephalitis, international travel requires thorough advance coordination. Caregivers should arrange a comprehensive remote review of all medical records with the neurology team in Turkey before confirming travel arrangements.

Key practical considerations include:

  • Duration of hospital stay: Acute inpatient evaluation, antibody confirmation, and primary immunotherapy typically take two to four weeks. Patients may need an additional two to six weeks of specialised inpatient rehabilitation depending on clinical recovery.
  • Caregiver presence: An adult caregiver or family member must accompany the patient throughout the hospitalisation to assist with medical history, communication, and emotional support.
  • Long-term continuity: Immunosuppressive treatment often continues for 12 to 24 months to minimise relapse risk. The hospital provides a detailed discharge plan and liaises with your local physician for ongoing blood monitoring and medication maintenance.

When Travel Is Not Advisable and Warning Signs

Autoimmune encephalitis can progress rapidly, and international travel poses severe risks during unstable phases. Commercial flights must not be undertaken if the patient displays any of the following warning signs:

  • Frequent, uncontrolled seizures or episodes of status epilepticus.
  • Severe autonomic instability, including erratic heart rates, unstable blood pressure, or central hypoventilation requiring respiratory assistance.
  • Acute severe psychosis, profound confusion, or extreme agitation that cannot be safely managed during flight.
  • Deteriorating consciousness, stupor, or coma without dedicated air ambulance transport.

If any acute deterioration develops, seek emergency care at your nearest local medical centre immediately. Travel abroad should only be considered once the treating physician issues written clearance confirming clinical stability.

Frequently asked questions

Infectious encephalitis is triggered directly by pathogens such as herpes simplex virus or bacteria entering the brain tissue. In contrast, autoimmune encephalitis occurs when the body's own immune system produces antibodies that erroneously attack neural receptors or brain proteins without an active infection. Diagnostic testing, including lumbar puncture and specialised antibody panels, differentiates between the two causes to determine whether antimicrobial or immunosuppressive therapy is required.

Comprehensive neural antibody panels evaluated in cerebrospinal fluid and serum typically take between seven and fourteen days to yield conclusive results. Because testing involves specialised immunofluorescence or cell-based assays, Turkish hospitals often initiate empirical first-line immunotherapy, such as high-dose intravenous steroids, while awaiting laboratory confirmation if clinical features strongly point toward an autoimmune inflammatory process.

Yes. In paraneoplastic autoimmune encephalitis, autoantibodies are initially generated by the immune system in response to an occult neoplasm, such as an ovarian teratoma in anti-NMDAR encephalitis or small cell lung cancer in other antibody syndromes. Identifying and surgically resecting the tumour is a vital component of therapy, as failing to remove it often impedes recovery and increases recurrence risk.

Neurological recovery from autoimmune encephalitis is typically gradual, often requiring several months to more than a year. While initial immunotherapy reduces acute brain inflammation, cognitive rehabilitation, speech therapy, and psychological support are essential for resolving lingering deficits in memory, emotional regulation, and motor skills. Regular consultations and periodic antibody monitoring help your medical team assess functional progress and minimise relapse risks.

Patients can fly home once their treating physician provides written clearance confirming neurological and autonomic stability. Travel is permitted when seizures are controlled, vital signs are steady, and acute delirium has resolved. For international flights, medical escort services or airline special assistance can be organised if the patient has residual mobility challenges or requires monitoring during transit.

Free personalised quote